These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 23965883
1. [Long-term outcomes and factors for predicting ventricular arrhythmia in patients with catecholaminergic polymorphic ventricular tachycardia]. Yu SY, Shen JH, Lu JP, Zhao DS, Zhang G, Geng J, Shan QJ. Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):671-7. PubMed ID: 23965883 [Abstract] [Full Text] [Related]
2. U-waves and T-wave peak to T-wave end intervals in patients with catecholaminergic polymorphic ventricular tachycardia, effects of beta-blockers. Viitasalo M, Oikarinen L, Väänänen H, Kontula K, Toivonen L, Swan H. Heart Rhythm; 2008 Oct; 5(10):1382-8. PubMed ID: 18929323 [Abstract] [Full Text] [Related]
3. [Mid-term clinical condition and prognosis in adrenergic ventricular tachycardia in children with apparently normal hearts]. Drago F, Vignati G, Agostino DA, Mauri L, Calzolari A, Figini A, Ragonese P. G Ital Cardiol; 1997 Apr; 27(4):349-56. PubMed ID: 9244739 [Abstract] [Full Text] [Related]
4. [Clinical features of six patients with catecholaminergic polymorphic ventricular tachycardia]. Zhao DS, Shen JH, Lu JP, Yu SY, Zhang G, Geng J, Shan QJ. Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):844-8. PubMed ID: 23302672 [Abstract] [Full Text] [Related]
10. Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. van der Werf C, Zwinderman AH, Wilde AA. Europace; 2012 Feb; 14(2):175-83. PubMed ID: 21893508 [Abstract] [Full Text] [Related]
17. Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia. Leren IS, Saberniak J, Majid E, Haland TF, Edvardsen T, Haugaa KH. Heart Rhythm; 2016 Feb 01; 13(2):433-40. PubMed ID: 26432584 [Abstract] [Full Text] [Related]
19. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, Saito A, Kurosaki K, Jouo K, Koujiro M, Konishi S, Matsuoka S, Oono T, Hayakawa S, Miura M, Ushinohama H, Shibata T, Niimura I. Heart; 2003 Jan 01; 89(1):66-70. PubMed ID: 12482795 [Abstract] [Full Text] [Related]
20. Ventricular tachycardia and exercise related syncope in children with structurally normal hearts: emphasis on repolarisation abnormality. Noh CI, Song JY, Kim HS, Choi JY, Yun YS. Br Heart J; 1995 Jun 01; 73(6):544-7. PubMed ID: 7626354 [Abstract] [Full Text] [Related] Page: [Next] [New Search]